Validation of a criterion-based screening and triage pathway for adult ADHD: a prospective observational study of safety and operational efficiency
Protracted encephalopathy and subacute combined degeneration associated with chronic nitrous oxide use: a case report
Shifting the Overton Window: enhancing therapeutic outcomes for Māori experiencing Ngā Māuiui kai (eating disorders) through the integration of traditional Māori and Western healing systems in Aotearoa New Zealand
Guide DNA — not RNA — expands the CRISPR toolkit
Nature Biotechnology, Published online: 15 May 2026; doi:10.1038/s41587-026-03138-9
Cas12 nucleases can use guide DNA instead of guide RNA, which switches their targets from DNA to RNA.
Widespread DNA off-targeting confounds RNA chromatin occupancy studies
Nature Biotechnology, Published online: 15 May 2026; doi:10.1038/s41587-026-03130-3
Many long noncoding RNA–DNA binding peaks detected using common assays arise from technical artifacts.
DNA-guided CRISPR–Cas12 for cellular RNA targeting
Nature Biotechnology, Published online: 15 May 2026; doi:10.1038/s41587-026-03129-w
ΨDNA guides are used with Cas12 for precise, programmable targeting of cellular RNA.
What Galen’s dissections reveal about tacit learning in modern medical education
Nature Medicine, Published online: 15 May 2026; doi:10.1038/s41591-026-04412-8
What Galen’s dissections reveal about tacit learning in modern medical education
Favipiravir for Lassa fever: an open-label, randomized controlled phase 2 trial
Nature Medicine, Published online: 15 May 2026; doi:10.1038/s41591-026-04402-w
An open-label, randomized controlled phase 2 trial comparing favipiravir with ribavirin for the treatment of mild-to-moderate Lassa fever in Nigeria found that favipiravir was safe and well tolerated and supports its further optimization as a treatment alternative.
Population-scale genomic medicine with the Hong Kong Genome Project
Nature Medicine, Published online: 15 May 2026; doi:10.1038/s41591-026-04410-w
Part of the Hong Kong Genome Project, genomic analyses of more than 20,000 participants provide information on clinically relevant variants for the Chinese population and offer insights on the implementation of genomic medicine initiatives.

